$ USD 1 USD = 1,0000 $ € EUR 1 USD = 0,8667 € R$ BRL 1 USD = 5,1502 R$ £ GBP 1 USD = 0,7420 £ ¥ JPY 1 USD = 155,1072 ¥ Fr CHF 1 USD = 0,8188 Fr C$ CAD 1 USD = 1,3914 C$ A$ AUD 1 USD = 1,4032 A$ ¥ CNY 1 USD = 6,7268 ¥ HK$ HKD 1 USD = 7,8450 HK$ S$ SGD 1 USD = 1,2728 S$ NZ$ NZD 1 USD = 1,7374 NZ$ kr SEK 1 USD = 9,7786 kr kr NOK 1 USD = 9,3474 kr kr DKK 1 USD = 6,4783 kr ₽ RUB 1 USD = 84,2817 ₽ ₹ INR 1 USD = 96,0008 ₹ R ZAR 1 USD = 16,2622 R ₺ TRY 1 USD = 48,6676 ₺ Mex$ MXN 1 USD = 17,1497 Mex$ ₩ KRW 1 USD = 1.360,6625 ₩ zł PLN 1 USD = 3,7628 zł ฿ THB 1 USD = 33,2950 ฿ Rp IDR 1 USD = 17.687,8531 Rp ﷼ SAR 1 USD = 3,7500 ﷼ د.إ AED 1 USD = 3,6725 د.إ $ ARS 1 USD = 1.506,6836 $ $ CLP 1 USD = 957,1853 $ $ COP 1 USD = 3.103,9993 $ Kč CZK 1 USD = 21,0599 Kč
Filtrando por: tag: pancreatic - Exibindo 1 - 5 de 5 notícias.
imagem
27/08/2026 03:54
FDA approves landmark pancreatic cancer drug that's shown to improve survival
U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer, by block...
imagem
26/08/2026 13:48
FDA gives expedited approval to new groundbreaking pancreatic cancer drug
FDA officials approve first-of-a-kind pill called daraxonrasib to fight one of the deadliest types of cancerThe US Food and Drug Administration (FDA) ...
imagem
31/05/2026 23:50
Daily pill doubles survival time for pancreatic cancer patients
The drug, daraxonrasib, has been hailed as a breakthrough in managing the deadliest of all the major cancers.
imagem
31/05/2026 10:00
Experimental pill promises new hope for deadly pancreatic cancer
A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments fo...
imagem
12/05/2026 06:00
She's trying to outrun pancreatic cancer. Breakthrough treatments give her hope
Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have more reason to hope than e...

A informação é poder quando bem usada.

— Autor desconhecido